Has Elber Camacho received payments from drug or device companies?

Yes. Drug and device makers reported $55,571 in general payments to Elber Camacho across 301 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Elber Camacho did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Elber Camacho come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Elber Camacho

Hematology & Oncology · la Quinta, CANPI 1598761710

Payments from drug & device makers

$55,571in general payments, 2019–2025

Across 301 payments — averaging $184.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bristol Myers Squibb$33K
E.r. Squibb & Sons, L.L.C.$8K
AstraZeneca$4K
Gilead$2K
Epizyme, Inc.$2K
Johnson & Johnson$570
plus $7K from 53 others

What the payments were for

Consulting fees$4,38028%
Speaking & faculty fees$1,50010%
Food & beverage$9,33961%
Education$1521%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bristol Myers Squibb	12	$33,417
E.r. Squibb & Sons, L.L.C.	43	$7,562
AstraZeneca	31	$4,287
Gilead(2 entities)	7	$1,686
Epizyme, Inc.	1	$1,500
Johnson & Johnson(2 entities)	24	$570
Merck	16	$499
Regeneron Healthcare Solutions, Inc.	10	$458
Genentech USA, Inc.	8	$434
Amgen	10	$370
GSK	3	$350
Incyte Corporation	7	$293
Pfizer	8	$265
Novocure Inc.	2	$238
Sanofi	9	$237
Karyopharm Therapeutics Inc.	6	$227
Daiichi Sankyo Inc.	7	$204
AbbVie	9	$196
Novartis	4	$184
Pharmacyclics LLC, An Abbvie Company	4	$165
Eisai Inc.	7	$163
Galvanize Therapeutics, Inc	1	$158
Puma Biotechnology, Inc.	3	$154
Bayer	3	$150
Sobi, Inc	2	$149
Telix Pharmaceuticals	1	$147
Jazz Pharmaceuticals Inc.	2	$142
Secura Bio, Inc.	3	$130
Array Biopharma Inc	6	$106
Rigel Pharmaceuticals, Inc.	5	$101
Pharmaessentia USA Corporation	3	$89
Takeda Pharmaceuticals U.S.A., Inc.	3	$82
Seagen Inc.	4	$69
Kyowa Kirin, Inc.	3	$61
Janssen Scientific Affairs, LLC	2	$61
Beone Medicines USA, Inc.	2	$54
EMD Serono, Inc.	2	$50
Boehringer Ingelheim	3	$43
EUSA Pharma (US) LLC	2	$42
AMAG Pharmaceuticals, Inc.	2	$41
Monteris Medical Corporation	2	$35
Coherus Oncology, Inc.	2	$35
Intuitive Surgical	1	$35
Taiho Oncology, Inc.	1	$33
Beigene USA, Inc.	1	$29
Springworks Therapeutics, Inc.	1	$26
Tolmar Pharmaceuticals, Inc.	1	$25
AVEO Pharmaceuticals, Inc.	1	$24
Exelixis Inc.	1	$22
Verastem, Inc.	1	$22
Abbott	1	$20
Mylan Institutional Inc.	1	$20
Blueprint Medicines Corporation	1	$19
Teva Pharmaceuticals USA, Inc.	1	$17
Helsinn Therapeutics (U.S.), Inc.	1	$17
Lilly USA, LLC	1	$16
Ipsen Biopharmaceuticals, Inc	1	$15
Dova Pharmaceuticals	1	$13
Servier Pharmaceuticals LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,571 in reported general payments places this provider in the 70th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California →

Other hematology & oncology in la Quinta

Alain AlgaziSan Francisco$119.2M
David BerzLos Angeles$43.3M
Jonathan GoldmanSanta Monica$35.7M
Omid HamidSanta Monica$23.7M
Nicholas McAndrewLos Angeles$22.9M
Aditya BardiaSanta Monica$22.1M
Joseph TuscanoSacramento$20.4M
Zev WainbergSanta Monica$19.3M
Caitlin CostelloSan Diego$16.9M
Rana McKaySan Diego$15.3M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →